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studies demonstrate that cortical inter-
stitial fibroblasts contain all the needed 
machinery to respond to hypoxia by 
expressing EPO. See page 312.
Atypical hemolytic 
uremic syndrome and 
complement mutations
Atypical hemolytic uremic syndrome 
(HUS) is often associated with muta-
tion in the complement pathway. Bien-
aime et al. examined 202 patients with 
atypical HUS and found that about 10% 
had mutations in complement factor I. 
The clinical outcome was unfavorable, 
and half of these patients died or devel-
oped end-stage renal disease. Remark-
ably, several of these patients were 
compound heterozygotes carrying muta-
tions in other complement factors. These 
excellent phenotype–genotype correl-
ations emphasize the need for genetic 
screening in patients with atypical HUS. 
See page 339.
Specific interstitial 
renal fibroblasts 
express HIF-2α  
and regulate  
EPO production
The production of erythropoietin 
(EPO) is under the control of the 
hypoxia-sensing pathway, which requires 
the inter action between the transcrip-
tion factor hypoxia-inducible factor 
(HIF) and a prolyl-hydroxylase, von 
Hippel–Lindau protein. As they report 
in this issue, Paliege et al. examined the 
localization of the two subunits of HIF, 
HIF-1α and HIF-2α, aiming to identify 
the type of cells that express these pro-
teins and that thus might regulate the 
expression of EPO. The authors used an 
inhibitor of the prolyl-hydroxylase that 
results in upregulation of EPO. Remark-
ably, using double immunolocaliza-
tion, they discovered that only cortical 
interstitial fibroblasts overexpressed 
HIF-2α and EPO. No colo calization 
of EPO and HIF-1α was found. These 
Autosomal recessive PKD
Mutations in the fibrocystin gene 
(PKHD1) cause autosomal reces-
sive polycystic kidney disease (PKD). 
Denamur et al., as they report in this 
issue, studied the severity of the phe-
notype in 54 fetuses and 20 neonates, 
correlating the severity with the type of 
mutation. The authors found that when 
two truncating mutations are present, 
they predict neonatal death. Children 
who survive have at least one missense 
mutation. Half of the mutations resulted 
in truncation of fibrocystin. As gesta-
tional age increased, so did the severity 
of the cystic dilatation in the collecting 
ducts and hepatic ducts. Interestingly, 
the more severe the mutation, the more 
the cystic dilatation extended into the 
cortex. But the presence of two severe 
mutations always results in early fetal 
death. See page 350.
It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
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